|
The British National Formulary (BNF) is a pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the National Health Service (NHS), including indication(s), contraindications, side effects, doses, legal classification, names and prices of available proprietary and generic formulations, and any other notable points.〔(【引用サイトリンク】title=Products: British National Formulary )〕 Though it is a national formulary, it nevertheless also includes entries for some medicines which are not available under the NHS and must be prescribed and/or bought privately. A symbol clearly denotes such drugs in their entry. It is used by pharmacists and doctors (both general practitioners and specialist practitioners), and by other prescribing healthcare professionals (such as nurses, pharmacy technicians, paramedics, and dentists) as a reference for correct dosage, indication, interactions and side effects of drugs. It is also used as a reassurance by those administering drugs, for example a nurse on a hospital ward, and even for patients and others seeking an authoritative source of advice on any aspect of pharmacotherapy. The British Pharmacopoeia (BP) specifies quality standards for the making of drugs listed in the BNF. ==Development== Many individuals and organisations contribute towards the preparation of the BNF. It is jointly published by the Royal Pharmaceutical Society and the BMJ Group, which is owned by the British Medical Association. It is published under the authority of a Joint Formulary Committee which comprises representatives of the two professional bodies and the Department of Health. Information on drugs is drawn from the manufacturers' product literature, medical and pharmaceutical literature, regulatory authorities and professional bodies. Advice is constructed from clinical literature and reflects, as far as possible, an evaluation of the evidence from diverse sources. The BNF also takes account of authoritative national guidelines and emerging safety concerns. In addition, the Joint Formulary Committee takes advice on all therapeutic areas from expert clinicians; this ensures that the BNF's recommendations are relevant to practice. However, in September 2013 the National Institute for Health and Care Excellence (NICE) in the UK opened a consultation on its draft decision not to give NICE accreditation to the processes to produce BNF publications following a review by an independent advisory committee. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「British National Formulary」の詳細全文を読む スポンサード リンク
|